Microinvasive cervical carcinoma and cervical intraepithelial neoplasia: Biologic significance and clinical implications of 72-kDa metalloproteinase immunostaining

Gynecologic Oncology

Volumn 61, Issue 2, 1996, Pages 197-203

  Garzetti, G Gioele ^a   Ciavattini, Andrea ^a   Lucarini, Guendalina ^a   Goteri, Gaia ^a   De Nictolis, Michele ^a   Biagini, Graziella ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE; VIRUS DNA;

ADULT; ARTICLE; CANCER INVASION; COLPOSCOPY; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX DYSPLASIA; VIRUS INFECTION; WART VIRUS;

EID: 0029867524     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0124     Document Type: Article

References (30)

1. Van den Hooff, A. Connective tissue as an active participant in the process of malignant growth, Anticancer Res. 6, 775-780 (1986).
2. Dvorak, H. F. Tumors: Wounds that do not heal, similarities between tumor stroma generation and wound healing, N. Engl. J. Med. 315, 1650-1659 (1986).
3. Aznavoorian, S., Murphy, A. N., Stetlet-Stevenson, G., and Liotta, L. A. Molecular aspects of tumor cell invasion and metastasis, Cancer 71, 1369-1383 (1993).
4. Liotta, L. A., Abe, S., Robey, P., and Martin, G. Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor, Proc. Natl. Acad. Sci. USA 76, 2268-2272 (1979).
5. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen, Nature 284, 67-68 (1980).
6. Matrisian, L., and Bowden, T. (1980). Stromelysin/transin and tumor progression, Semin. Cancer Biol. 1, 107-115 (1990).
7. Nasiell, K., Roger, U., and Nasiell, M. Behavior of mild cervical dysplasia during long-term follow-up, Obstet. Gynecol. 67, 665-669 (1986).
8. Brown, M., and Phillips, G. Management of the mildy abnormal pap smear: A conservative approach, Gynecol. Oncol. 22, 149-153 (1985).
9. Mitchell, H., Drake, M., and Medley, G. Prospective evaluation of risk of cervical cancer after cytological evidence of human papillomavirus infection, Lancet 1, 573-575 (1986).
10. Vayhynen, M., Syrjanen, K., Castren, O., and Mantyjarvi, R. Colposcopy in women with papillomavirus lesions of the uterine cervix, Obstet. Gynecol. 65, 409-415 (1985).
11. Garzetti, G. G., Ciavattini, A., Goteri, G., Menzo, S., De Nictolis, M., Clementi, M., Brugia, M., and Romanini, C. Vaginal micropapillary lesions are not related to human papillomavirus infection: In situ hybridization and polymerase chain reaction detection technique, Gynecol. Obstet. Invest. 38, 134-139 (1994).
12. Monteagudo, C., Merino, M. J., San Juan, J., Liotta, L. A., and Stetler-Stevenson, W. G. Immunohistochemical distribution of the type IV collagenase in normal, benign and malignant breast tissue, Am. J. Pathol. 136, 585-592 (1990).
13. D'Errico, A., Biagini, G., Garbisa, S., Milani, M., Rizzoli, R., Vasi, V., Villanacci, V., Grigioni, W. F., and Mancini, A. M. Detection of extracellular matrix antigen (fibronectin, laminin, type IV collagen) in paraffin embedded sections by avidin-biotin-peroxidase complex labeling, Basic Appl. Histochem. 30, 325-332 (1986).
14. Daidone, M. G., Silvestrini, R., and D'Errico, A. Laminin receptors, collagenase IV and prognosis in node negative breast cancer, Int. J. Cancer 47, 529-532 (1991).
15. Bonfil, R. D., Reddel, R. R., Ura, H., Reich, R., Fridman, R., Harris, C. C., and Klein Szanto, J. P. Invasive and metastatic potential of a v-Ha-ras-transformed human bronchial epithelial cell line, J. Natl. Cancer Inst. 81, 587-594 (1989).
16. Garbisa, S., Pozzatti, R., Muschel, R. J., Saffiotti, U., Ballin, M., Goldfarb, R. H., Khoury, G., and Liotta, L. A. Secretion of type IV collagenolytic protease and metastatic phenotype: Induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-Ela, Cancer Res. 47, 1523-1528 (1987).
17. Muschel, R. J., Williams, J. E., Lowy, D. R., and Liotta, L. A. Harvey ras induction of metastatic potential dependent upon oncogene activation and the type of recipient cell, Am. J. Pathol. 121, 1-8 (1985).
18. Ura, H., Bonfil, R. D., Reich, R., Reddel, R., Pfeifer, A., Harris, C. C., and Klein, A. J. P. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells, Cancer Res. 49, 4615-4621 (1989).
19. D'Errico, A., Garbisa, S., Liotta, L. A., Castronovo, V., Stetler-Stevenson, W. G., and Griogioni, W. G. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression, Mod. Pathol. 4, 239-246 (1991).
20. Levy, A. T., Cioce, V., Sobel, M. E., Garbisa, S., Griogioni, W. F., Liotta, L. A., and Stetler-Stevenson, W. G. Increased expression of the 72 kDa type IV collagenase in human colonie adenocarcinoma, Cancer Res. 51, 439-444 (1991).
21. Poulsom, R., Pignatelli, M., Stetler-Stevenson, W. G., Liotta, L., Wright, P. A., Jeffery, R. E., Longcroft, J. M., Rogers, L., and Stamp, G. W. Stromal expression of 72 kDa type IV collagenase (72 kDa metalloproteinase) and TIMP-2 mRNAs in colorectal neoplasia, Am. J. Pathol. 141, 389-396 (1992).
22. Campo, E., Merino, M. J., Tavassoli, F. A., Charonis, A. S., Stetler-Stevenson, W. G., and Liotta, L. A. Evaluation of basement membrane components and the 72 kDa type IV collagenase in serous tumors of the ovary, Am. J. Surg. Pathol. 16, 500-507 (1992).
23. Pyke, C., Ralfkiaer, E., Huhtala, P., Hurskainein, T., Dano, K., and Tryggvason, K. Localization of messenger RNA for M 72,000 and 92,000 type IV collagenase in human skin cancers by in situ hybridization, Cancer Res. 52, 1336-1341 (1992).
24. Richart, R. M., and Wright, T. C., Jr. Controversies in the management of low-grade cervical intraepithelial neoplasia, Cancer 71, 1413-1421 (1993).
25. Hellberg, D., Nilsson, S., and Valentin, J. Positive cervical smear with subsequent normal colposcopy and histology - Frequency of CIN in a long-term follow-up, Gynecol. Oncol. 53, 148-151 (1994).
26. Morrison, E. A. B. Natural history of cervical infection with human papillomavirus, Clin. Infect. Dis. 18, 172-180 (1994).
27. Iwasaka, T., Yokoyama, M., Matsus, N., Fukuda, K., Mvula, M., and Sugimori, H. In situ hybridization analysis of human papillomavirus DNA in cervical intraepithelial neoplasia. Prospective follow-up study, cervix lfgt 12, 55-60 (1994).
28. Kenemans, P. HPV genotype as a prognostic factor for progression to cervical carcinoma in young women, Eur. J. Obstet. Gynecol. Reprod. Biol. 55, 24-25 (1994).
29. zur Hausen, H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers, Cancer Res. 49, 4677-4681 (1989).
30. Durst, M., Croce, C. M., Gissman, L., Schwaz, E., and Huebner, K. Papillomavirus sequences integrate near cellulars, Proc. Natl. Acad. Sci. USA 84, 1970-1974 (1987).